Article
Contrast-enhanced MRI-based radiomics signatures as new markers for preoperative assessment of the EGFR mutation and subtypes from bone metastases
2022-06-02
Abstract excerpt
<h4>Background: </h4> To develop and externally validate contrast-enhanced (CE) T1-weighted MRI-based radiomics for the identification of epidermal growth factor receptor (EGFR) mutation, exon-19 deletion and exon-21 L858R mutation with the spinal bone metastasis from primary lung adenocarcinoma. Methods The study enrolled 159 patients from our hospital between Jan. 2017 and Sep. 2021 to form a primary set, and 2...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 047db5f0-4bbb-5a75-91a9-01e35f18bd3e
- DOI
- 10.21203/rs.3.rs-1620579/v1
